With the first commercial TIL therapy brewing at Iovance, along with various clinical readouts which are set to come to fruition in 2023, the race is on for the next generation of modified TIL to enter the clinic.

Returning as the only forum to address bottlenecks in end-to-end TIL development, the 5th TIL Therapies Summit is designed exclusively for TIL experts to fast-track your program into the clinic and beyond.

Unite with this niche community across industry and academia as pioneers from Iovance Biotherapeutics, Turnstone Biologics, Achilles Therapeutics and Lyell Immunopharma share clinical updates, next-gen engineering, and novel innovations to turbocharge preclinical and clinical development of safe, scalable and effective TIL therapies.

With 23+ expert speakers, 8 new companies and a brand-new Manufacturing & Characterization Bootcamp, you won’t want to miss this unrivalled opportunity to connect and collaborate with industry leaders.

Don’t let your team get left behind! Join us as we accelerate the next wave of TIL therapies into the clinic and beyond. Find out more – https://ter.li/mk23q3.